Litcius/Paper detail

Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?

Andrew I. Ritchie, Aran Singanayagam

2020The Lancet295 citationsDOIOpen Access PDF

Topics & Concepts

ImmunosuppressionInflammationMedicineImmunologyCoronavirus disease 2019 (COVID-19)Systemic inflammationDiseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCoronavirusPathologyInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesInflammasome and immune disordersLong-Term Effects of COVID-19
Immunosuppression for hyperinflammation in COVID-19: a double-edged sword? | Litcius